A Pilot, Randomized, Double-blind, Placebo-controlled Single-center Study to Evaluate the Safety and Efficacy of SUBSYS (Fentanyl Sublingual Spray) for the Treatment of Acute Procedure-related Pain in a Monitored Setting

Trial Profile

A Pilot, Randomized, Double-blind, Placebo-controlled Single-center Study to Evaluate the Safety and Efficacy of SUBSYS (Fentanyl Sublingual Spray) for the Treatment of Acute Procedure-related Pain in a Monitored Setting

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors INSYS Therapeutics, Inc
  • Most Recent Events

    • 04 Oct 2017 Planned initiation date changed from 30 Sep 2017 to 30 Nov 2017.
    • 31 Aug 2017 Planned initiation date changed from 31 Aug 2017 to 30 Sep 2017.
    • 31 Jul 2017 Planned initiation date changed from 31 Jul 2017 to 31 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top